Differentiated Thyroid Cancer in Asians

Overview

Journal Endocrinol Metab (Seoul)

Specialty Endocrinology

Date 2016 Mar 22

PMID 26996424

Authors

Bo Hyun Kim

Affiliations

Soon will be listed here.

References

Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack W . Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995. Cancer Causes Control. 2000; 11(2):163-70. DOI: 10.1023/a:1008932123830. View

Ahn H, Kim H, Welch H . Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med. 2014; 371(19):1765-7. DOI: 10.1056/NEJMp1409841. View

Jin H, Pinheiro P, Xu J, Amei A . Cancer incidence among Asian American populations in the United States, 2009-2011. Int J Cancer. 2015; 138(9):2136-45. PMC: 5283572. DOI: 10.1002/ijc.29958. View

Kim T, Kim W, Kim W, Shong Y . Current status and future perspectives in differentiated thyroid cancer. Endocrinol Metab (Seoul). 2014; 29(3):217-25. PMC: 4192824. DOI: 10.3803/EnM.2014.29.3.217. View

Jung K, Won Y, Kong H, Oh C, Cho H, Lee D . Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015; 47(2):127-41. PMC: 4398120. DOI: 10.4143/crt.2015.060. View

Kolonel L . Cancer incidence among Filipinos in Hawaii and the Philippines. Natl Cancer Inst Monogr. 1985; 69:93-8. View

Sampson E, Brierley J, Le L, Rotstein L, Tsang R . Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007; 110(7):1451-6. DOI: 10.1002/cncr.22956. View

Ito Y, Nikiforov Y, Schlumberger M, Vigneri R . Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol. 2013; 9(3):178-84. DOI: 10.1038/nrendo.2012.257. View

Verburg F, Mader U, Tanase K, Thies E, Diessl S, Buck A . Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab. 2012; 98(1):172-80. DOI: 10.1210/jc.2012-2458. View

10.

Goodman M, Yoshizawa C, Kolonel L . Descriptive epidemiology of thyroid cancer in Hawaii. Cancer. 1988; 61(6):1272-81. DOI: 10.1002/1097-0142(19880315)61:6<1272::aid-cncr2820610636>3.0.co;2-8. View

11.

Lo T, Uy A, Maningat P . Well-Differentiated Thyroid Cancer: The Philippine General Hospital Experience. Endocrinol Metab (Seoul). 2016; 31(1):72-9. PMC: 4803565. DOI: 10.3803/EnM.2016.31.1.72. View

12.

Fernandes J, Day T, Richardson M, Sharma A . Overview of the management of differentiated thyroid cancer. Curr Treat Options Oncol. 2004; 6(1):47-57. DOI: 10.1007/s11864-005-0012-3. View

13.

Kus L, Shah M, Eski S, Walfish P, Freeman J . Thyroid cancer outcomes in Filipino patients. Arch Otolaryngol Head Neck Surg. 2010; 136(2):138-42. DOI: 10.1001/archoto.2009.206. View

14.

Lo T, Canto A, Maningat P . Risk Factors for Recurrence in Filipinos with Well-Differentiated Thyroid Cancer. Endocrinol Metab (Seoul). 2015; 30(4):543-50. PMC: 4722410. DOI: 10.3803/EnM.2015.30.4.543. View

15.

Chen A, Jemal A, Ward E . Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115(16):3801-7. DOI: 10.1002/cncr.24416. View